Oh hell, instead of just predicting outcome tell us the outcome so you can fix the problems of those that don't have a good outcome. Action, not talk.
http://journal.frontiersin.org/article/10.3389/fneur.2016.00245/full?
- Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Assessment of ischemic stroke lesions on computed tomography (CT) or
MRI using the Alberta Stroke Program Early CT Score (ASPECTS) is widely
used to guide acute stroke treatment. We aimed to review the current
evidence on ASPECTS. Originally, the score was developed for
standardized lesion assessment on non-contrast CT (NCCT). Early studies
described ASPECTS as a predictor of functional outcome and symptomatic
intracranial hemorrhage after iv-thrombolysis with a threshold of ≤7
suggested to identify patients at high risk. Following studies rather
pointed toward a linear relationship between ASPECTS and functional
outcome. ASPECTS has also been applied to assess perfusion CT and
diffusion-weighted MRI (DWI). Cerebral blood volume ASPECTS proved to be
the best predictor of outcome, outperforming NCCT-ASPECTS in some
studies. For DWI-ASPECTS varying thresholds to identify patients at risk
for poor outcome were reported. ASPECTS has been used for patient
selection in three of the five groundbreaking trials proving efficacy of
mechanical thrombectomy published in 2015.
ASPECTS values predict
functional outcome after thrombectomy. Moreover, treatment effect of
thrombectomy appears to depend on ASPECTS values being smaller or not
present in low ASPECTS, while patients with ASPECTS 5–10 do clearly
benefit from mechanical thrombectomy. However, as patients with low
ASPECTS values were excluded from recent trials data on this subgroup is
limited. There are several limitations to ASPECTS addressed in a
growing number of studies. The score is limited to the anterior
circulation, the template is unequally weighed and correlation with
lesion volume depends on lesion location. Overall ASPECTS is a useful
and easily applicable tool for assessment of prognosis in acute stroke
treatment and to help guide acute treatment decisions regardless whether
MRI or CT is used. Patients with low ASPECTS values are unlikely to
achieve good outcome. However, methodological constraints of ASPECTS
have to be considered, and based on present data, a clear cutoff value
to define “low ASPECTS values” cannot be given.
Introduction
The Alberta Stroke Program Early Computed Tomography
Score (ASPECTS) is widely used in clinical practice to assess the extent
of early ischemic changes on brain imaging for acute stroke treatment.
ASPECTS has been applied to various imaging modalities in acute stroke
imaging since its introduction in 2000. ASPECTS is a 10-point scoring
system with anatomical regions distributed over the MCA territory (
1).
It was designed as a robust imaging measure to predict
outcome in intravenous thrombolysis. ASPECTS has drawn a lot of
attention due to its use for patient exclusion in the 2015 trials
demonstrating efficacy of mechanical thrombectomy (
2–
4).
Due to high efficacy, we will see an increase of
mechanical thrombectomy over the course of the next years and with it
probably an increasing use of ASPECTS in routine clinical practice, as
patient stratification is key in this time-dependent treatment. There
are also a rapidly growing number of scientific studies using ASPECTS in
stroke research or addressing methodological questions concerning
ASPECTS (please see Figure
1
for an overview of the number of studies published per year over the
last 10 years). This article aims to summarize the current evidence on
ASPECTS in a topical and selective review and to explain its
applications in clinical practice and trials.
No comments:
Post a Comment